Compare TBPH & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | FBRT |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | 223 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 662.7M |
| IPO Year | 2013 | N/A |
| Metric | TBPH | FBRT |
|---|---|---|
| Price | $16.08 | $8.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $18.40 | $11.50 |
| AVG Volume (30 Days) | 289.3K | ★ 778.3K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 15.83% |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $12.34 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | ★ N/A | $13.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.98 | $8.24 |
| 52 Week High | $21.03 | $11.84 |
| Indicator | TBPH | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 40.51 | 42.89 |
| Support Level | $13.41 | $8.64 |
| Resistance Level | $17.21 | $9.26 |
| Average True Range (ATR) | 0.34 | 0.20 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 4.84 | 25.15 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.